FDA Inspection 1098988 — Apotex Inc.
The FDA completed an inspection of Apotex Inc. on June 28, 2019 in Richmond Hill. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 28, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Richmond Hill (Canada)